Medical Device and Healthcare Industry Update — April 17, 2026
Osstem Implant has achieved EU MDR certification for its 'K3' and 'K5' dental unit chairs, signaling a push to expand equipment exports. Meanwhile, GC Wellbeing and Alteogen Biologics have joined forces to co-market the recombinant hyaluronidase 'Tergase' in the domestic market. Additionally, a major shift is underway in the medical device sector, with software-based devices now accounting for half of all clinical trials this year.
13 min read/15 sources
